These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9621565)

  • 1. [Mechanism of resistance of Shigella flexneri 2a resistant to new quinolone antibiotics].
    Oonaka K; Fukuyama M; Tanaka M; Sato K; Ohnishi K; Ajima I; Murata M
    Kansenshogaku Zasshi; 1998 Apr; 72(4):365-70. PubMed ID: 9621565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of bacillary dysentery caused by new quinolone-resistant Shigella flexneri 2a].
    Yoshimura K; Kawashima I; Obana M; Matsuoka Y; Irimajiri S; Oonaka K; Fukuyama M
    Kansenshogaku Zasshi; 1998 Sep; 72(9):935-8. PubMed ID: 9796193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone Resistance Mechanisms in Shigella Isolates in Shanghai, China, Between 2010 and 2015.
    Zhang WX; Chen HY; Tu LH; Xi MF; Chen M; Zhang J
    Microb Drug Resist; 2019 Mar; 25(2):212-218. PubMed ID: 30307807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011.
    Qin T; Bi R; Fan W; Kang H; Ma P; Gu B
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2037-2045. PubMed ID: 27620866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae.
    Broskey J; Coleman K; Gwynn MN; McCloskey L; Traini C; Voelker L; Warren R
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():95-9. PubMed ID: 10824039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S; Wretlind B
    Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
    Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tosufloxacin against bacterial enteric pathogens.
    Glick EJ; Segreti J; Goodman LJ; Trenholme GM
    Diagn Microbiol Infect Dis; 1990; 13(4):333-6. PubMed ID: 2076595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the DNA gyrA gene mutation with resistance to fluoroquinolones in Staphylococcus aureus isolated from patients].
    Fang Z; Song X; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):24-6. PubMed ID: 12501604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
    King A; Bethune L; Phillips I
    J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
    Takahata M; Yonezawa M; Matsubara N; Watanabe Y; Narita H; Matsunaga T; Igarashi H; Kawahara M; Onodera S; Oishi Y
    J Antimicrob Chemother; 1997 Sep; 40(3):383-6. PubMed ID: 9338491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.